Related Experiment Video
Updated: Mar 21, 2026

07:49
Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
6.6K
The Fourth International Symposium on Genetic Disorders of the Ras/MAPK pathway
David A Stevenson1, Lisa Schill2, Lisa Schoyer2
1Stanford University, Stanford, California.
American Journal of Medical Genetics. Part A
|May 8, 2016
Summary
RASopathies are genetic disorders from Ras/MAPK pathway gene variations. This summary of the 4th International Symposium highlights current knowledge gaps in these frequent conditions.
Area of Science:
- Genetics and Molecular Biology
- Developmental Biology
- Clinical Medicine
Background:
- RASopathies encompass a spectrum of genetic disorders stemming from alterations in the Ras/MAPK signaling pathway.
- This group includes conditions such as neurofibromatosis type 1 (NF1), Noonan syndrome, and Costello syndrome, among others.
- Collectively, RASopathies represent a significant category of frequently occurring genetic disorders.
Framework:
- The 4th International Symposium on Genetic Disorders of the Ras/MAPK pathway convened experts to discuss advancements.
- Focus areas included the genetic underpinnings and clinical manifestations of RASopathies.
- The symposium served as a platform for collaborative discussion and knowledge exchange.
Implementation:
- This report synthesizes the key discussions and findings presented at the symposium.
- It identifies and elaborates on the current limitations and unanswered questions within RASOPATHY research.
- The proceedings aim to guide future research directions and clinical management strategies.
Implications:
- Addressing the identified knowledge gaps is crucial for improving diagnostic accuracy and therapeutic interventions for RASopathies.
- Enhanced understanding of the Ras/MAPK pathway will facilitate the development of targeted treatments.
- This summary provides a roadmap for future research, aiming to improve outcomes for affected individuals.
More Related Videos
Related Concept Videos
MAPK Signaling Cascades
9.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.1K
The Ras Gene
7.5K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
7.5K
Interactions Between Signaling Pathways
7.8K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.8K
Small GTPases - Ras and Rho
5.7K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
5.7K
The Ras Gene
2.4K
2.4K
PI3K/mTOR/AKT Signaling Pathway
6.2K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
6.2K

